FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800667086> ?p ?o ?g. }

• W2800667086 endingPage "506" @default.
• W2800667086 startingPage "499" @default.
• W2800667086 abstract "Metformin, a widely used biguanide class of anti-diabetic drug, has potential to increase insulin sensitivity and reduce blood glucose to treat type 2 diabetes (T2D). It has been reported that metformin has an activity on regulation of miRNAs by targeting several downstream genes in metabolic pathways. However, molecular mechanism underlying the process is still not fully known. In this study, it was aimed to identify differential expression profiles of plasma derived miRNAs following 3 months metformin treatment in patients with T2D.The plasma samples of 47 patients with T2D (received no anti-diabetic treatments) and plasma samples of same 47 patients received 3 months metformin treatment was recruited to the study. Total RNAs were isolated from plasma and reverse transcribed into cDNA. Profiles of differential expressions of miRNAs in plasma were assessed by using of micro-fluidic based multiplex quantitative real time -PCR (BioMarkTM 96.96 Dynamic Array).Our results showed that expression profiles of 13 candidate miRNAs; hsa-let-7e-5p, hsa-let-7f-5p, hsa-miR- 21-5p, hsa-miR-24-3p, hsa-miR-26b-5p, hsa-miR-126-5p, hsa-miR-129-5p, hsa-miR-130b-3p, hsa-miR-146a-5p, hsamiR- 148a-3p, hsa-miR-152-3p, hsa-miR-194-5p, hsa-miR- 99a-5p were found significantly downregulated following metformin treatments in patients with T2D (p<0.05).In conclusion, our finding could provide development of better and more effective miRNAs based therapeutic strategies against T2D.Metformin je široko upotrebljavan anti-dijabetični lek iz klase bigvanidina, koji potencijalno povećava insulinsku senzitivnost i umanjuje nivo glukoze u krvi pri tretmanu dijabetesa tip 2 (T2D). Ima podataka da metformin deluje i na regulisanje miRNA preko nekoliko niskosilaznih gena u metaboličkim putevima. Međutim, molekularni mehanizmi u ovom procesu nisu još uvek u potpunosti poznati. U ovom izučavanju svrha je bila da se identifikuju različiti ekspresioni profili miRNK u plazmi nakon tretmana T2D pacijenata sa metforminom.Analizirani su uzorci plazme 47 pacijenata sa T2D (koji nisu bili na anti-dijabetičnom tretmanu) i uzorci plazme 47 pacijenata koji su 3 meseca primali metformin. Ukupna RNA je izolovana iz plazme i reverzno transkribovana u cDNK. Profili različitih ekspresija miRNK analizirani su primenom mikro-fluidne multipleks kvantitativne real-time PCR (BioMarkTM 96.96 Dynamyc Array).Dobijeni rezultati pokazuju da je nađena ekspresija 13 kandidata miRNK; hsa-let-b-5p, hsa-let-7f-5p, hsamiR21-5p, hsa-miR-24-3p, hsa-miR-26-5p, hsa-miR-126-5p, hsa-miR-129, hsa-miR-130-3p, hsa-miR-146-5p, hsa-miR-148a-3p, hsa-miR-152-3p, hsa-miR-194-5p, hsa-miR-99a-5p, značajno snižena nakon tretmana metforminom pacijenata sa T2D (p<0,05).Može se zaključiti da naši rezultati mogu unaprediti terapeutsku strategiju T2D zasnovanu na efektima miRNK." @default.
• W2800667086 created "2018-05-17" @default.
• W2800667086 creator A5015684113 @default.
• W2800667086 creator A5019673982 @default.
• W2800667086 creator A5039926262 @default.
• W2800667086 creator A5051465967 @default.
• W2800667086 creator A5062897848 @default.
• W2800667086 creator A5063706585 @default.
• W2800667086 creator A5088062781 @default.
• W2800667086 date "2018-12-01" @default.
• W2800667086 modified "2023-10-10" @default.
• W2800667086 title "Profiles of Circulating miRNAs Following Metformin Treatment in Patients with Type 2 Diabetes" @default.
• W2800667086 cites W1648301895 @default.
• W2800667086 cites W1997003352 @default.
• W2800667086 cites W1998771362 @default.
• W2800667086 cites W2016112105 @default.
• W2800667086 cites W2042871909 @default.
• W2800667086 cites W2044003590 @default.
• W2800667086 cites W2051573465 @default.
• W2800667086 cites W2057860524 @default.
• W2800667086 cites W2061998727 @default.
• W2800667086 cites W2064039435 @default.
• W2800667086 cites W2075317528 @default.
• W2800667086 cites W2096611464 @default.
• W2800667086 cites W2115103884 @default.
• W2800667086 cites W2130842459 @default.
• W2800667086 cites W2131762882 @default.
• W2800667086 cites W2132892030 @default.
• W2800667086 cites W2134907909 @default.
• W2800667086 cites W2142504521 @default.
• W2800667086 cites W2146654374 @default.
• W2800667086 cites W2149966907 @default.
• W2800667086 cites W2157523007 @default.
• W2800667086 cites W2157841460 @default.
• W2800667086 cites W2158170204 @default.
• W2800667086 cites W2161068194 @default.
• W2800667086 cites W2161253430 @default.
• W2800667086 cites W2162674813 @default.
• W2800667086 cites W2163918978 @default.
• W2800667086 cites W2164882663 @default.
• W2800667086 cites W2168261002 @default.
• W2800667086 cites W2169583353 @default.
• W2800667086 cites W2255457724 @default.
• W2800667086 cites W2425790260 @default.
• W2800667086 cites W2742200852 @default.
• W2800667086 cites W2795070146 @default.
• W2800667086 doi "https://doi.org/10.2478/jomb-2018-0009" @default.
• W2800667086 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6298473" @default.
• W2800667086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30584410" @default.
• W2800667086 hasPublicationYear "2018" @default.
• W2800667086 type Work @default.
• W2800667086 sameAs 2800667086 @default.
• W2800667086 citedByCount "72" @default.
• W2800667086 countsByYear W28006670862019 @default.
• W2800667086 countsByYear W28006670862020 @default.
• W2800667086 countsByYear W28006670862021 @default.
• W2800667086 countsByYear W28006670862022 @default.
• W2800667086 countsByYear W28006670862023 @default.
• W2800667086 crossrefType "journal-article" @default.
• W2800667086 hasAuthorship W2800667086A5015684113 @default.
• W2800667086 hasAuthorship W2800667086A5019673982 @default.
• W2800667086 hasAuthorship W2800667086A5039926262 @default.
• W2800667086 hasAuthorship W2800667086A5051465967 @default.
• W2800667086 hasAuthorship W2800667086A5062897848 @default.
• W2800667086 hasAuthorship W2800667086A5063706585 @default.
• W2800667086 hasAuthorship W2800667086A5088062781 @default.
• W2800667086 hasBestOaLocation W28006670861 @default.
• W2800667086 hasConcept C104317684 @default.
• W2800667086 hasConcept C126322002 @default.
• W2800667086 hasConcept C134018914 @default.
• W2800667086 hasConcept C145059251 @default.
• W2800667086 hasConcept C185592680 @default.
• W2800667086 hasConcept C2777180221 @default.
• W2800667086 hasConcept C2777688063 @default.
• W2800667086 hasConcept C2780035454 @default.
• W2800667086 hasConcept C2780323712 @default.
• W2800667086 hasConcept C2781188995 @default.
• W2800667086 hasConcept C3020134792 @default.
• W2800667086 hasConcept C43617362 @default.
• W2800667086 hasConcept C55493867 @default.
• W2800667086 hasConcept C555293320 @default.
• W2800667086 hasConcept C60644358 @default.
• W2800667086 hasConcept C71924100 @default.
• W2800667086 hasConcept C86803240 @default.
• W2800667086 hasConcept C98274493 @default.
• W2800667086 hasConceptScore W2800667086C104317684 @default.
• W2800667086 hasConceptScore W2800667086C126322002 @default.
• W2800667086 hasConceptScore W2800667086C134018914 @default.
• W2800667086 hasConceptScore W2800667086C145059251 @default.
• W2800667086 hasConceptScore W2800667086C185592680 @default.
• W2800667086 hasConceptScore W2800667086C2777180221 @default.
• W2800667086 hasConceptScore W2800667086C2777688063 @default.
• W2800667086 hasConceptScore W2800667086C2780035454 @default.
• W2800667086 hasConceptScore W2800667086C2780323712 @default.
• W2800667086 hasConceptScore W2800667086C2781188995 @default.
• W2800667086 hasConceptScore W2800667086C3020134792 @default.
• W2800667086 hasConceptScore W2800667086C43617362 @default.
• W2800667086 hasConceptScore W2800667086C55493867 @default.

• next